Zanubrutinib,Bendamustine,Rituximab,Venetoclax
Beigene,Roche,Abbvie
['$bgne', 'beigene']
$bgne beigene highlights promising data from blood cancer portfolio and pipeline at the european hematology association hybrid congress - 
News and analysis of biomedical, biopharma, biotech, biosciences, pharmaceutical, and technology equities